Home/Filings/4/0001213900-23-017206
4//SEC Filing

Oron Assaf 4

Accession 0001213900-23-017206

CIK 0001739174other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 3:57 PM ET

Size

5.4 KB

Accession

0001213900-23-017206

Insider Transaction Report

Form 4
Period: 2023-03-01
Oron Assaf
Chief Business Officer
Transactions
  • Award

    Common Stock Options - Right to Buy

    2023-03-01+50,00050,000 total
    Exercise: $0.40Exp: 2033-03-01Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 1, 2024, and the remainder vesting in 12 equal quarterly installments over three years.

Documents

1 file

Issuer

BiomX Inc.

CIK 0001739174

Entity typeother

Related Parties

1
  • filerCIK 0001792310

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 3:57 PM ET
Size
5.4 KB